Nebulised BromAc in Healthy Volunteers

Clinical trial NCT05220605 · COMPLETED

Trial details

NCT number: NCT05220605
Sponsor: Mucpharm Pty Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Pneumonia Bromelains Adverse Reaction Acetylcysteine Adverse Reaction Mucus; Plug COVID-19 Acute Respiratory Distress Syndrome

Start date: 2022-07-27
Primary completion: 2022-08-14
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.